22157.jpg
Global Cell & Gene Therapy Drug Delivery Research Report 2023: Market Exhibits Surge with Enhanced Focus on Personalized Medicine and Rise in Chronic Diseases - Trends, Opportunities, and Forecasts to 2028
31 janv. 2024 10h02 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By...
ocugen_4C_LOGO (002).png
Ocugen to Present at Pharma Market Research Conference
31 janv. 2024 08h00 HE | Ocugen
MALVERN, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Asia-Pacific Cell and Gene Therapy Biomanufacturing Market
Asia-Pacific Cell and Gene Therapy Biomanufacturing Analysis and Forecast, 2022-2031 - A $8.60 Billion Projected Market by 2031
30 janv. 2024 13h04 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell and Gene Therapy Biomanufacturing Market - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's...
European Gene Editing Technologies Market
Europe's Gene Editing Technologies Market, Valued at $370 Million in 2023, is Set to Reach $3.26 Billion by 2032 - Country-Specific Insights for Agriculture & Biomedical Applications Unveiled
30 janv. 2024 07h50 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe gene...
U.S. Cell and Gene Therapy Clinical Trial Services Market
U.S. Cell and Gene Therapy Clinical Trial Services Market 2024-2030: A $28.58 Billion Opportunity
29 janv. 2024 11h34 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...
Adverum_Primary_Medium.png
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
29 janv. 2024 08h00 HE | Adverum Biotechnologies, Inc.
REDWOOD CITY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for...
22157.jpg
Cloning and Mutagenesis Global Market Research Report 2024: Market to Surge to $6.07 Billion by 2028 with a CAGR of 18.8% - Long-term Forecasts to 2033
25 janv. 2024 08h06 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cloning and Mutagenesis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global cloning and mutagenesis...
22157.jpg
Cell & Gene Therapy Manufacturing Services Global Research Report 2024: Market to Witness Significant Growth with Projected CAGR of 16.6% by 2028 - Long-term Forecast to 2033
25 janv. 2024 05h27 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Manufacturing Services Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
Primary Immunodeficiency Therapeutics Market to Surpass $11 Billion by 2030 with Significant Advancement in Genetic Research and Diagnostic Technologies
24 janv. 2024 12h27 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Primary Immunodeficiency Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
22157.jpg
Gene Therapy Collaboration and Licensing Deals Report: Comprehensive Analysis of Trends from 2016-2023
24 janv. 2024 07h19 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. Announcing a pivotal resource...